Cargando…

The Effect of Antiarrhythmic Drugs on the Beat Rate Variability of Human Embryonic and Human Induced Pluripotent Stem Cell Derived Cardiomyocytes

Embryonic stem cell (ESC) derived tissue is a promising tool to be used in different clinical, preclinical and also scientific settings, for example as in vivo biological pacemaker, preclinical drug safety screening tool or ultimately as part of a cell replacement therapy. However, before ESC derive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niehoff, Julius, Matzkies, Matthias, Nguemo, Filomain, Hescheler, Jürgen, Reppel, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773847/ https://www.ncbi.nlm.nih.gov/pubmed/31575920 http://dx.doi.org/10.1038/s41598-019-50557-7

Ejemplares similares

Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar
por: Gupta, Manoj K, et al.
Publicado: (2010)

Human Pluripotent Stem Cell-Derived Cardiomyocytes: Response to TTX and Lidocain Reveals Strong Cell to Cell Variability
por: Sheng, Xiaowu, et al.
Publicado: (2012)

Evidence for a Critical Role of Catecholamines for Cardiomyocyte Lineage Commitment in Murine Embryonic Stem Cells
por: Lehmann, Martin, et al.
Publicado: (2013)

In vitro effect of hydroxychloroquine on pluripotent stem cells and their cardiomyocytes derivatives
por: Kamga Kapchoup, Michelle Vanessa, et al.
Publicado: (2023)

Effect of Ethanolic Extract of Vernonia amygdalina on the Proliferation, Viability and Function of Mouse Induced Pluripotent Stem Cells and Cardiomyocytes
por: Nguemfo Tchankugni, Arlette, et al.
Publicado: (2023)

Assessment of the In Vitro Cytotoxicity Effects of the Leaf Methanol Extract of Crinum zeylanicum on Mouse Induced Pluripotent Stem Cells and Their Cardiomyocytes Derivatives
por: Ndjenda II, Magloire Kanyou, et al.
Publicado: (2021)

Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations
por: Hamad, Sarkawt, et al.
Publicado: (2019)

Cyclooxygenases Inhibitors Efficiently Induce Cardiomyogenesis in Human Pluripotent Stem Cells
por: Nemade, Harshal, et al.
Publicado: (2020)

The L-type Ca(2+) Channels Blocker Nifedipine Represses Mesodermal Fate Determination in Murine Embryonic Stem Cells
por: Nguemo, Filomain, et al.
Publicado: (2013)

The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients
por: Fatima, Azra, et al.
Publicado: (2013)

Parabolic, Flight-Induced, Acute Hypergravity and Microgravity Effects on the Beating Rate of Human Cardiomyocytes
por: Acharya, Aviseka, et al.
Publicado: (2019)

Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation
por: Brodarac, Andreja, et al.
Publicado: (2015)

Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival
por: Wagh, Vilas, et al.
Publicado: (2023)

Correction: Nemade, H.; et al. Cyclooxygenases Inhibitors Efficiently Induce Cardiomyogenesis in Human Pluripotent Stem Cells. Cells 2020, 9, 554
por: Nemade, Harshal, et al.
Publicado: (2020)

Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach
por: Paci, Michelangelo, et al.
Publicado: (2017)

Decreased beating rate variability of cultured cardiomyocytes by endotoxin
por: Schmidt, H, et al.
Publicado: (1999)

Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Gaballah, Mahmoud, et al.
Publicado: (2022)

Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment
por: Chaudhari, Umesh, et al.
Publicado: (2015)

Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
por: Chaudhari, Umesh, et al.
Publicado: (2017)

Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes
por: Eng, George, et al.
Publicado: (2016)

MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes
por: Chaudhari, Umesh, et al.
Publicado: (2016)

Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
por: Christ, Torsten, et al.
Publicado: (2021)

Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells
por: Nemade, Harshal, et al.
Publicado: (2018)

Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
por: Chaudhari, Umesh, et al.
Publicado: (2017)

Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism
por: Yang, Li, et al.
Publicado: (2021)

Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1
por: Xu, Qiang, et al.
Publicado: (2022)

Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
por: Shiti, Assad, et al.
Publicado: (2021)

The Effects of Pharmacological Compounds on Beat Rate Variations in Human Long QT-Syndrome Cardiomyocytes
por: Kuusela, Jukka, et al.
Publicado: (2016)

Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure
por: Gherghiceanu, Mihaela, et al.
Publicado: (2011)

Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus
por: Seck, Insa, et al.
Publicado: (2021)

Differentiation of human adipose-derived stem cells into beating cardiomyocytes
por: Choi, Yu Suk, et al.
Publicado: (2010)

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Huang, Mengying, et al.
Publicado: (2021)

Impact of human autoantibodies on β(1)-adrenergic receptor conformation, activity, and internalization
por: Bornholz, Beatrice, et al.
Publicado: (2013)

Electrophysiological Properties of Tetraploid Cardiomyocytes Derived from Murine Pluripotent Stem Cells Generated by Fusion of Adult Somatic Cells with Embryonic Stem Cells
por: Xu, Guoxing, et al.
Publicado: (2023)

Directed Differentiation of Zebrafish Pluripotent Embryonic Cells to Functional Cardiomyocytes
por: Xiao, Yao, et al.
Publicado: (2016)

Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
por: Parsons, Xuejun H., et al.
Publicado: (2011)

Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes
por: Zhao, Qi, et al.
Publicado: (2017)

Emergent synchronous beating behavior in spontaneous beating cardiomyocyte clusters
por: Sakamoto, Kazufumi, et al.
Publicado: (2021)

Beat-to-beat dynamic regulation of intracellular pH in cardiomyocytes
por: Lyu, Yankun, et al.
Publicado: (2021)

Prostanoid Receptors Involved in Regulation of the Beating Rate of Neonatal Rat Cardiomyocytes
por: Mechiche, Hakima, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dfdlkr94ii4sk7kppkjsos69cj